SUMMARY Four hundred and ninety two samples of serum from blood donors were screened for the presence of antibodies specific to cytomegalovirus using radioimmunoassay, a modified complement fixation test, and five commercially available tests: the Cetus CMV IHA, Abbott CMV total AB EIA, Cytomegalisa Stat EIA, Enzygnost EIA, and Virenz G-CMV EIA. A wide variation in results was found, with only 53*5% of the sera giving total concordance by all methods. Rates of seropositivity in the different tests ranged from 34-9% to 59-3%, with sensitivities ranging from 75 2% to 99*1% compared with the radioimmunoassay. Of 211 sera which gave positive results with four or more of the tests, none was negative by the radioimmunoassay and Abbott EIA, three were negative in Cetus IHA and Enzygnost EIA, and 11 were negative in the modified complement fixation test. Virenz G and Cytomegalisa Stat ETAs, however, gave 40 (19%) and 49 (23.2%), respectively, as negative. The results confirmed the reliability of the radioimmunoassay for the detection of the antibody status to CMV, but this test is too elaborate for a screening procedure. The Abbott EIA and Cetus IHA were found to be the most suitable for this purpose in spite of high false positive rates.
It is well known that cytomegalovirus can be transmitted by blood transfusion. Recently, infection with cytomegalovirus has been shown to cause serious complications, especially in neonates receiving exchange transfusions and in patients undergoing bone marrow transplantation. ' No marker is currently available for directly screening donated blood for the presence of cytomegalovirus. Donors can be tested for antibodies to cytomegalovirus indicating past infection with the virus, but this has been shown to correlate positively with the risk of transmitting cytomegalovirus via the donated blood.23 Consequently, there is an increasing demand for the screening of blood and blood products destined for specific groups of patients for cytomegalovirus antibody. No generally accepted test, however, for cytomegalovirus antibodies has yet been established. Highly sensitive radioimmunoassays and enzyme immunoassays have been described for the detection of cytomegalovirus antibody,45 but these Accepted for publication 2 May 1985 are not suitable for laboratories lacking the necessary expertise and specialist equipment to perform such tests. Likewise, immunofluorescence techniques have been evaluated, but, for practical reasons, these are generally considered to be unsuitable for screening on a large scale. 67 Several commercial screening test kits for cytomegalovirus are now available that are primarily aimed at blood transfusion laboratories. It is clear, however, that many of these assays have not been fully evaluated in routine screening practice. We therefore compared the performance of five commercial kits currently available as screening tests for the detection of cytomegalovirus antibodies in 492 blood donors with the complement fixation test and a highly sensitive in-house radioimmunoassay.
Material and methods

SPECIMENS
Samples of clotted blood were collected from 492 healthy blood donors over two years. Once in the laboratories the sera were decanted into sterile containers and stored frozen at -20°C. 1059 Grint, Ronalds, Kangro, Campbell-Benzie, Ward, Hardiman, Heath TESTS Complement fixation test A modified complement fixation test was used8 to increase sensitivity. The serum and complement were allowed to react for 18 hours at 1 5°C instead of the usual 4°C.9 For comparative purposes those sera that were positive (-1:8) by this method were further tested by the standard complement fixation method.
In both methods commercial cytomegalovirus complement fixation and control antigens (Hoechst UK Ltd) were used at the same dilution.
Radioimmunoassay
The assay used was an indirect solid phase radioimmunoassay, which had been developed and evaluated in the department.5 10 Fifty ,ul aliquot of test serum diluted 1/100 and 1/400 were added to duplicate microtitre wells containing cytomegalovirus or control antigens (Hoechst UK Ltd) identical to those used in the modified complement fixation test. After incubation at 37°C for 150 minutes the plates were washed three times and 50 ,l of '25I-labelled goat antihuman IgG (Tago), containing about 40 000 counts/minute, was added to each well. After further incubation at 37°C for 60 minutes the plates were washed 15 times and the radioactivity that had been bound in individual wells was counted in an NE1600 gamma counter (Nuclear Enterprises Ltd). A binding ratio, obtained by dividing the mean counts per minute for each dilution of serum by the background radioactivity, was determined. The virus specific binding index for each sample of serum was calculated by dividing the binding ratio with viral antigen by the binding ratio with control antigen. A specific binding index of over 2, at either dilution of serum, was taken to indicate the presence of virus specific antibody.
Commercial cytomegalovirus antibody tests
The commercial test kits assessed were an indirect haemagglutination assay, Cetus cytomegalovirus IHA (Diamed Diagnostics Ltd), and four enzyme immunoassays (EIA): Abbott CMV total AB EIA (Abbott Laboratories); Cytomegalisa Stat (MA Bioproducts supplied by Laboratory Impex Ltd); Enzygnost EIA (Hoechst UK Ltd), and Virenz G-CMV EIA (Northumbria Biologicals Ltd). Each test was performed strictly in accordance with the manufacturer's instructions.
The absorbance values for the Virenz G, Enzygnost, and Cytomegalisa Stat tests were determined using a Titertek Multiskan Photometer type 310C. The absorbance values for the Abbott EIA were determined using a Quantum II analyser, on loan from Abbott Laboratories. Results considered to be borderline by any test method were retested in accordance with the manufacturer's recommendations. Test sensitivity, specificity, and accuracy were calculated as described by Griner et al." The test procedures for each kit were, briefly, as follows: Cetus IHA A 50 ,ul volume of a 1/4 dilution of serum was pipetted in to each of two wells in a "V" well microtitre plate. Twenty five ,.l of cytomegalovirus test cells were added to one well and the same volume of control cells added to the second well. The tests were read after a minimum incubation time of 90 minutes at room temperature. The detection of cytomegalovirus specific antibody was indicated by the presence of partial or complete agglutination in the test well and its absence in the control well.
Abbott EIA Ten A.l of serum was added to 200 ,ul of serum diluent in a well of a reaction tray. A polystyrene bead coated with cytomegalovirus antigen was added to each well. The trays were incubated at 40°C for 60 minutes and the beads were washed. Two hundred ,l of horseradish peroxidase conjugated goat antihuman immunoglobulin was added and the trays were reincubated for 30 minutes. After washing the beads were transferred to individual assay tubes. Three hundred ,ul of 0-phenylenediamine hydrochloride substrate was added and the tubes were left for 30 minutes at room temperature. The reaction was halted by the addition of 1 ml of 1N H2SO4 and the absorbance was then read at 492 nm. Test specimens with absorbance values equal to or greater than the cut off value, based on the positive and negative control sera supplied, were denoted reactive for antibody to cytomegalovirus. Virenz G EIA One hundred ,ul of a 1/50 dilution of test serum was added to a microtitration well coated with cytomegalovirus antigen, with a further 100 ,u aliquot added to an adjacent uncoated control well. After incubation at room temperature for 30 minutes the wells were washed and 100 ,l. of horseradish peroxidase conjugated swine antihuman IgG added. After further incubation for one hour at room temperature and subsequent washing 100 Iul of substrate 3,3', 5,5' tetramethyl benzidine was added. The colour change was allowed to develop for 30 minutes at room temperature, halted by the addition of 100 ,ul of 5N H2SO4 and the absorbance read at 450 nm. Sera, giving a corrected absorbance value (value of well coated with cytomegalovirus minus value of control well) greater than that of the low positive control serum, were considered positive for cytomegalovirus specific antibody. Enzygnost EIA One hundred and fifty ,ul volumes of serum diluent were dispensed into wells coated with cytomegalovirus and control antigen. Fifty ,ul of Antibody screening tests for cytomegalovirus a 1/11 dilution of serum was then added to both wells. The test plate was incubated for 60 minutes at 37°C and then washed. Fifty Al of alkaline phosphatase conjugated rabbit antihuman IgG was added and the plates were reincubated for 60 minutes at 37°C and washed. One hundred ,ul of p-nitrophenyl phosphate substrate was added with a further incubation of 30 minutes at 37°C. The enzyme reaction was halted by the addition of 50 ,ul of 2N sodium hydroxide and the absorbance values were read at 405 nm. Sera were considered cytomegalovirus antibody positive if the differences in absorbance values between the test and control wells was >0-2 absorbance units. Cytomegalisa Stat EIA Five u1l of test serum was mixed with 100 ,ul of serum diluent in a test and control well coated with antigen and incubated for 15 minutes at room temperature on a plate shaker. After washing 100 ul of alkaline phosphatase conjugated rabbit antihuman IgG was added and the "removawell" plate was reincubated for 15 minutes at room temperature on the plate shaker. After washing 100 Al of phenolphthalein monophosphate substrate solution was added and the colour change developed at room temperature for 15 minutes on the plate shaker. The reaction was halted by the addition of 200 ,ul 0 1N sodium hydroxide. Absorbance values were read at 550 nm. A positive test result was defined as an absorbance value equivalent to or greater than the mean absorbance value of the two low positive serum controls provided.
Results Table 1 shows the results of the tests. Two hundred and sixty three (53.5%) of the 492 sera tested gave concordant results by all test methods, 116 sera were positive, and 147 sera negative. The prevalence of cytomegalovirus antibody by the different tests ranged from 34-9% in the cytomegalisa stat EIA, to 59 3 % in the cetus IHA. On the basis of the proportion of positive results, the tests can broadly Modified complement fixation and radioimmunoassay When the modified complement fixation and radioimmunoassay procedures routinely used in this laboratory were compared 474 (96.3%) of the sera gave concordant results ( Table 2 ). Of the 18 discordant sera 14 were positive in the radioimmunoassay but negative in the modified complement fixation. Eleven of these 14 sera also gave positive results in three or more of the commercial assays, providing supporting evidence for the presence of cytomegalovirus specific antibody in these samples. Table 3 shows the reaction profiles of the remaining three sera (nos 10, 133, and 439). These sera gave very weak positive results in radioimmunoassay and were positive by only one other test method: possibly, these were false positive radioimmunoassay results. Similarly, the four modified complement fixation positive but radioimmunoassay negative sera were reactive only in a maximum of two other tests, Cetus IHA or Abbott EIA, or both, the Cetus IHA results showing agglutination of control cells and, therefore, probably not genuinely positive for cytomegalovirus specific antibody. The 204 modified complement fixation positive sera were also tested using the conventional method of incubation overnight at +4°C. Of these, only 150 (73%) were positive at a 1/4 dilution, showing the lower sensitivity of this method. Clearly, of the three established in house techniques, the radioimmunoassay was the most sensitive for screening purposes. Consequently, the performance of each commercial assay was compared with that of the radioimmunoassay (Table 2) .
Comparing each of the tests against the others, we found that radioimmunoassay showed the best agreement. No sera were identified as antibody positive or negative by the radioimmunoassay alone, in contrast to the other assays, and only three RIA positive sera (Table 3) were positive in less than three other tests. Conversely, only three of the radioimmunoassay negative sera were positive by a maximum of three other tests. If a concordance in at least four of the seven tests is accepted as indicative of the presence of cytomegalovirus specific antibody then the sensitivity and specificity of the radioimmunoassay were 100% and 98-9%, respectively; the overall agreement of the radioimmunoassays with the other tests was then 99-4%. group.bmj.com on July 9, 2017 -Published by http://jcp.bmj.com/ Downloaded from Gnint, Ronalds, Kangro, Campbell-Benzie, Ward, Hardiman, Heath Performance values calculated according to Griner et al. " In general, the commercial kits were found to be simple to use, although the Enzygnost EIA is, if used as a screening test, somewhat intricate in its present form, and the accompanying instructions are difficult to follow. This particular assay is relatively expensive and the reagents are not marketed in kit form. In the Cytomegalisa Stat EIA technical difficulties were encountered with the poorly fitting plastic "removawell" system. A further factor of importance to laboratories relying on commercial tests is the possible batch variation of the products. This aspect, however, was outside the scope of the present study.
With all the test kits, results can be obtained within three to four hours. An advantage of the Cetus IHA test is that the test plates can be retained for up to 18 hours whereas in the enzyme immunoassays the results have to be read within one to two hours.
The preliminary work necessary to establish the radioimmunoassay is considerable and requires designated radioisotope facilities, which may not be available in all laboratories. The test is also labour intensive to perform and therefore unsuitable as a screening procedure. The incubation time of 18 hours for the modified complement fixation test precludes it as a screening procedure in many instances. Nevertheless, the modified complement fixation test could be considered when results obtained on the same day are not essential.
From the results of this study, the Cetus IHA and Abbott EIA would seem to be the tests best suited for screening purposes. The testing of the sera in the Abbott EIA is considerably aided by semiautomation, using the spectrophotometer and the equipment for bead washing supplied by the manufacturers. On the other hand, the Cetus IHA is simple to use and does not require specialised equipment; micro adaptations have been described661 and if a similar level of sensitivity is maintained in these adaptions this could seem to be a test which is well suited for laboratories lacking the facilities for enzyme immunoassays.
In conclusion, we found a significant variation in the sensitivity of the different assays available, which must be a cause of concern to those considering the use of a commercial kit for the screening for antibodies to cytomegalovirus. We regard this considerable variation in performance as a serious problem requiring immediate attention. At present, no licencing or national reference system exists to define minimum standards for such commercial products-shortcomings which must be remedied.
